PMID: 9169588May 1, 1997Paper

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration

The Biochemical Journal
M L Billingsley, R L Kincaid

Abstract

This review attempts to summarize what is known about tau phosphorylation in the context of both normal cellular function and dysfunction. However, conceptions of tau function continue to evolve, and it is likely that the regulation of tau distribution and metabolism is complex. The roles of microtubule-associated kinases and phosphatases have yet to be fully described, but may afford insight into how tau phosphorylation at the distal end of the axon regulates cytoskeletal-membrane interactions. Finally, lipid and glycosaminoglycan modification of tau structure affords yet more complexity for regulation and aggregation. Continued work will help to determine what is causal and what is coincidental in Alzheimer's disease, and may lead to identification of therapeutic targets for halting the progression of paired helical filament formation.

Citations

Feb 24, 2001·Journal of Neurochemistry·Q W FanM Michikawa
Aug 25, 2001·Annual Review of Neuroscience·V M LeeJ Q Trojanowski
Mar 11, 2004·Journal of Neurochemistry·Hong MaZhuohua Zhang
Sep 24, 2004·The Journal of Biological Chemistry·Patrizia FanaraMarc K Hellerstein
Apr 22, 2005·Acta Pharmacologica Sinica·Yan-qiu DengJian-zhi Wang
Nov 18, 2005·FEBS Letters·Atiqur RahmanAngel Cedazo-Mínguez
Jan 1, 2014·Antioxidants·Daniel P CardinaliLuis I Brusco
Jun 18, 2016·Cerebral Cortex·Benjamin KolisnykMarco A M Prado
Mar 28, 2017·Acta Neuropathologica·Gabriel PascualJaap Goudsmit
Jun 28, 2017·Biomedicines·Olusiji A AkinrinmadeStefan Barth
Apr 1, 2020·Chemical Society Reviews·Ayah AbdeldayemPatrick T Gunning
Aug 28, 2020·Frontiers in Aging Neuroscience·Ghazala IqbalTouqeer Ahmed
Oct 28, 1998·Physiological Reviews·E J Pettit, F S Fay
Dec 11, 2002·The European Journal of Neuroscience·Karsten SchmidtJürgen Götz
Oct 11, 2003·Journal of Neurochemistry·Mutsuki AmanoKozo Kaibuchi
Oct 19, 2006·Journal of Biomedicine & Biotechnology·Leonel RojoRicardo B Maccioni
Aug 10, 2007·Expert Opinion on Investigational Drugs·Alistair J StewartIllana Gozes
Jun 17, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cynthia Marie-ClaireFlorence Noble
May 3, 2006·The FEBS Journal·Gennady ErmakKelvin J A Davies
Dec 21, 2005·Acta Pharmacologica Sinica·Jian-zhi Wang, Ze-fen Wang
Jan 27, 2010·The Mount Sinai Journal of Medicine, New York·Maria Jose Metcalfe, Maria E Figueiredo-Pereira
Jan 3, 2014·Alzheimer's Research & Therapy·Melissa E MurrayPrashanthi Vemuri
Jul 17, 2013·International Journal of Molecular Sciences·Li LinQing Tian
Jun 12, 2013·Translational Neuroscience·Xin-An LiuSathyanarayanan V Puthanveettil

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.